Thatch
Series A | Remote
Company News Hub
No direct newsroom story is tagged to KRY yet. KRY does not have a direct story in this feed yet; the page uses company facts, founder context, geography, and market links as the working brief.
Company baseline
Healthcare | Series D
Profile, founder, and operating facts
Direct feed
No direct stories mapped yet
Use the brief before direct stories arrive
Operating market
Sweden
Sweden startup coverage
Funding lens
$160.00M, latest mapped round Series D (Accel, $160M Series D in 2022, $2.0B valuation)
Series D comparison route
KRY is currently mapped as a Healthcare company at the Series D stage, with operating context centered on Sweden. The company summary on this route is: KRY is transforming the world of healthcare by making care more accessible and convenient. Healthcare
Related topics
Use the story feed below for chronology, then bounce back to the company profile and hub pages when you need peer, geography, or stage-level comparison.
The direct feed is currently empty, so this hub acts as a structured brief instead of an article archive. It anchors KRY to its company profile, founders, stage, country, and industry routes without implying that a direct newsroom story has been published.
Comparable Healthcare companies in this view include Thatch, Tempo, Neuralink, Cedar, and SWORD Health. Use those comparisons with the Healthcare startup directory and Series D funding hub to keep the company view grounded in its operating peer set.
A company-news page is most useful when it connects individual updates to the surrounding market. For KRY, that means reading direct story links alongside the company's Healthcare category, Series D stage, and Sweden operating context. A single article can show what happened; the linked hubs help explain why it matters.
Use this page as a research checkpoint before comparing peers, founders, and funding rounds. The company profile gives the clean baseline, the Healthcare startup list shows the peer set, and the Sweden startup news hub adds geography-level movement. Together, those paths reduce the chance of treating a normal market update as an isolated signal.
When several of these signals move together, the page becomes more valuable than a simple article feed: it turns into a lightweight chronology of company momentum, sector pressure, and founder execution.
Funding context is currently recorded as $160.00M, latest mapped round Series D (Accel, $160M Series D in 2022, $2.0B valuation). The Series D funding news route helps compare whether the company is moving with its stage cohort or standing out from it.
Founder links appear here when mapped, so readers can move from company-level coverage to operator-level context. This is useful for understanding whether news is driven by product, market expansion, partnerships, hiring, or leadership execution.
For a broader comparison, open related companies, related topics, and the Healthcare startup directory. This makes the hub stronger for repeat research than a standalone news archive.
Peer Reading Path
We have not mapped a direct tagged article to KRY yet. In practice, that usually means the coverage is currently showing up inside broader healthcare or market-wide stories rather than on a single company-specific route.
This hub tracks tagged 100Xfounder coverage, founder references, funding context, hiring signals, and related market pages connected to KRY.
Some company mentions first appear inside broader sector, country, funding, or founder stories. When a direct article is mapped, it appears in this company-specific feed.
Start with the company profile, then compare the company against its industry, funding-stage, country, founder, and topic hubs for a wider execution view.